Showing results (1961-1970 of 2,338) with videos related to

Sort By:
Pageof 234
Neuropharmacology|October 15, 2021
Multitarget 2'-hydroxychalcones as potential drugs for the treatment of neurodegenerative disorders and their comorbiditiesFabiola Kamecki, Damijan Knez, Diego Carvalho, et al.
Arthritis Care & Research|April 25, 2017
Association Between Pain Sensitization and Disease Activity in Patients With Rheumatoid Arthritis: A Cross-Sectional StudyYvonne C Lee, Clifton O Bingham, Robert R Edwards, et al.
Physical Review Letters|August 18, 2025
Neutralization of Multiply Charged Ground-State Ions by Collective Electron Transfer from an EnvironmentLutz Marder, Catmarna Küstner-Wetekam, Nils Kiefer, et al.
Movement Disorders Clinical Practice|October 3, 2017
Frequency of GBA variants in autopsy-proven multiple system atrophyMiriam Sklerov, Un Jung Kang, Christopher Liong, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 30, 2016
Reductive Coupling of Diynes at Rhodium Gives Fluorescent Rhodacyclopentadienes or Phosphorescent Rhodium 2,2'-Biphenyl ComplexesCarolin Sieck, Meng Guan Tay, Marie-Hélène Thibault, et al.
Journal of the American Chemical Society|October 23, 2020
Pressure-Induced Polymerization of Polycyclic Arene-Perfluoroarene Cocrystals: Single Crystal X-ray Diffraction Studies, Reaction Kinetics, and Design of Columnar HydrofluorocarbonsAlexandra Friedrich, Ines E Collings, Kamil F Dziubek, et al.
Schizophrenia Bulletin|April 30, 2014
Schizophrenia--time to commit to policy changeW Wolfgang Fleischhacker, Celso Arango, Paul Arteel, et al.
Brain Stimulation|June 29, 2021
Subthreshold stimulation intensity is associated with greater clinical efficacy of intermittent theta-burst stimulation priming for Major Depressive DisorderJonathan C Lee, Juliana Corlier, Andrew C Wilson, et al.
Neuropsychology|January 24, 2008
Selective corticostriatal dysfunction in schizophrenia: examination of motor and cognitive skill learningKarin Foerde, Russell A Poldrack, Barbara J Khan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-beta inhibitorLisa J Green, Philip Marder, Chad Ray, et al.
Pageof 234